| Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis CJL Murray, KS Ikuta, F Sharara, L Swetschinski, GR Aguilar, A Gray, ... The Lancet 399 (10325), 629-655, 2022 | 3049 | 2022 |
| Effectiveness of Covid-19 vaccines against the B. 1.617. 2 (Delta) variant J Lopez Bernal, N Andrews, C Gower, E Gallagher, R Simmons, ... New England Journal of Medicine 385 (7), 585-594, 2021 | 2727 | 2021 |
| Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population … A Cassini, LD Högberg, D Plachouras, A Quattrocchi, A Hoxha, ... The Lancet infectious diseases 19 (1), 56-66, 2019 | 2290 | 2019 |
| Covid-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variant N Andrews, J Stowe, F Kirsebom, S Toffa, T Rickeard, E Gallagher, ... New England Journal of Medicine 386 (16), 1532-1546, 2022 | 1320 | 2022 |
| Assessing transmissibility of SARS-CoV-2 lineage B. 1.1. 7 in England E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ... Nature 593 (7858), 266-269, 2021 | 903 | 2021 |
| Antibody status and incidence of SARS-CoV-2 infection in health care workers SF Lumley, D O’Donnell, NE Stoesser, PC Matthews, A Howarth, ... New England Journal of Medicine 384 (6), 533-540, 2021 | 874 | 2021 |
| Clinical features and management of human monkeypox: a retrospective observational study in the UK H Adler, S Gould, P Hine, LB Snell, W Wong, CF Houlihan, JC Osborne, ... The Lancet Infectious Diseases 22 (8), 1153-1162, 2022 | 709 | 2022 |
| COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study VJ Hall, S Foulkes, A Saei, N Andrews, B Oguti, A Charlett, E Wellington, ... The Lancet 397 (10286), 1725-1735, 2021 | 668 | 2021 |
| The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use P Zarb, B Coignard, J Griskeviciene, A Muller, V Vankerckhoven, K Weist, ... Eurosurveillance 17 (46), 20316, 2012 | 614 | 2012 |
| Transmission of SARS-CoV-2 Lineage B. 1.1. 7 in England: Insights from linking epidemiological and genetic data E Volz, S Mishra, M Chand, JC Barrett, R Johnson, L Geidelberg, ... MedRxiv, 2020.12. 30.20249034, 2021 | 591 | 2021 |
| SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN) VJ Hall, S Foulkes, A Charlett, A Atti, EJM Monk, R Simmons, E Wellington, ... The Lancet 397 (10283), 1459-1469, 2021 | 554 | 2021 |
| Oral versus intravenous antibiotics for bone and joint infection HK Li, I Rombach, R Zambellas, AS Walker, MA McNally, BL Atkins, ... New England Journal of Medicine 380 (5), 425-436, 2019 | 530 | 2019 |
| Prevalence of healthcare-associated infections, estimated incidence and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results … C Suetens, K Latour, T Kärki, E Ricchizzi, P Kinross, ML Moro, B Jans, ... Eurosurveillance 23 (46), 1800516, 2018 | 470 | 2018 |
| Macrolide Resistance in Treponema pallidum in the United States and Ireland SA Lukehart, C Godornes, BJ Molini, P Sonnett, S Hopkins, F Mulcahy, ... New England Journal of Medicine 351 (2), 154-158, 2004 | 458 | 2004 |
| Duration of protection against mild and severe disease by Covid-19 vaccines N Andrews, E Tessier, J Stowe, C Gower, F Kirsebom, R Simmons, ... New England Journal of Medicine 386 (4), 340-350, 2022 | 405 | 2022 |
| Late Ebola virus relapse causing meningoencephalitis: a case report M Jacobs, A Rodger, DJ Bell, S Bhagani, I Cropley, A Filipe, RJ Gifford, ... The Lancet 388 (10043), 498-503, 2016 | 347 | 2016 |
| Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection V Hall, S Foulkes, F Insalata, P Kirwan, A Saei, A Atti, E Wellington, ... New England Journal of Medicine 386 (13), 1207-1220, 2022 | 338 | 2022 |
| The antibiotic course has had its day MJ Llewelyn, JM Fitzpatrick, E Darwin, C Gorton, J Paul, TEA Peto, ... Bmj 358, 2017 | 299 | 2017 |
| Effects of control interventions on Clostridium difficile infection in England: an observational study KE Dingle, X Didelot, TP Quan, DW Eyre, N Stoesser, T Golubchik, ... The Lancet Infectious Diseases 17 (4), 411-421, 2017 | 289 | 2017 |
| Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies AJ Kaasch, G Barlow, JD Edgeworth, VG Fowler Jr, M Hellmich, ... Journal of Infection 68 (3), 242-251, 2014 | 261 | 2014 |
